Key Findings:  These new findings offer a novel perspective in autism research and indicate that the EC system could represent a novel target option for autism pharmacotherapy.
Type of Study:  Meta-analysis
Study Result:  Positive
Study Location(s):  Italy, United States
Year of Pub:  2017
Cannabinoids Studied:  Anandamide (AEA), 2-Arachidonoyl Glycerol (2-AG)
Phytocannabinoid Source:  Not Applicable
Receptors Studied:  CB1, CB2